Vergoeding 2015-2019 voor ATC-subgroep G04BD : Middelen bij urge-incontinentie

  • Raming voor de totale Zvw-populatie
  2015 2016 2017 2018 2019
G04BD02 Flavoxaat (Urispas ®) 130.550 124.780 108.370 93.555 83.785
G04BD04 Oxybutynine (Dridase ®) 1.234.200 572.340 569.570 611.500 1.524.900
G04BD07 Tolterodine (Detrusitol ®) 537.470 474.630 459.730 534.560 681.460
G04BD08 Solifenacine (Vesicare ®) 13.283.900 13.485.600 12.889.000 12.466.200 11.703.000
G04BD10 Darifenacine (Emselex ®) 1.799.100 1.736.000 1.490.200 1.323.500 1.269.700
G04BD11 Fesoterodine (Toviaz ®) 1.542.900 1.477.100 1.373.600 1.273.700 1.272.100
G04BD12 Mirabegron (Betmiga ®) 2.990.000 3.548.700 4.349.300 5.113.800 5.692.700
Totaal 21.518.120 21.419.150 21.239.770 21.416.815 22.227.645